Mechanistic insight into the effect of BT-benzo-29 on the Z-ring in Bacillus subtilis

IUBMB Life. 2020 May;72(5):978-990. doi: 10.1002/iub.2234. Epub 2020 Jan 26.

Abstract

The assembly and disassembly of FtsZ play an essential role in bacterial cell division. Using single-cell imaging, we report that short exposure to BT-benzo-29 inhibits Z-ring formation in live Bacillus subtilis cells. Fluorescence recovery after photobleaching of the Z-ring in live bacteria demonstrated that BT-benzo-29 strongly suppressed the assembly dynamics of FtsZ in the Z-ring. Furthermore, B. subtilis cells expressing V275A-FtsZ resisted the antibacterial activity of BT-benzo-29 providing evidence that BT-benzo-29 inhibits bacterial proliferation by targeting FtsZ. In addition, a brief (8 min) exposure of BT-benzo-29 destroyed the Z-ring without perturbing the localization of a late cell division protein, DivIVA, the nucleoid segregation, and membrane permeability. BT-benzo-29, when used in combination with vancomycin and polymyxin B (PMB), produced a much stronger inhibitory effect on Bacillus subtilis and Escherichia coli cells, respectively. The combination index of BT-benzo-29 with vancomycin and PMB was determined to be <1, suggesting that BT-benzo-29 exhibits synergistic inhibitory effects on bacterial proliferation when used along with these antibiotics.

Keywords: FRAP; FtsZ inhibitors; Z-ring dynamics; bacterial cell division, BT-benzo-29; synergistic effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Anti-Bacterial Agents / pharmacology*
  • Bacillus subtilis / drug effects*
  • Bacillus subtilis / genetics
  • Bacillus subtilis / growth & development
  • Bacillus subtilis / metabolism
  • Bacterial Proteins / antagonists & inhibitors*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Benzimidazoles / pharmacology*
  • Cell Division / drug effects*
  • Cell Membrane Permeability / drug effects
  • Cytoskeletal Proteins / antagonists & inhibitors*
  • Cytoskeletal Proteins / genetics
  • Cytoskeletal Proteins / metabolism
  • Drug Combinations
  • Drug Resistance, Bacterial / genetics*
  • Drug Synergism
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / growth & development
  • Escherichia coli / metabolism
  • Fluorescence Recovery After Photobleaching
  • Gene Expression
  • Microbial Sensitivity Tests
  • Mutation
  • Polymyxin B / pharmacology
  • Single-Cell Analysis
  • Thiophenes / pharmacology*
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Benzimidazoles
  • Cytoskeletal Proteins
  • Drug Combinations
  • FtsZ protein, Bacteria
  • N-(4-sec-butylphenyl)-2-(thiophen-2-yl)-1H-benzo(d)imidazole-4-carboxamide
  • Thiophenes
  • Vancomycin
  • Polymyxin B